DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR TIOTROPIUM BROMIDE

« Back to Dashboard

Clinical Trials for Tiotropium Bromide

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00139932	Tiotropium Bromide Alone vs Tiotropium Bromide and Formoterol Fumarate in Subjects With COPD (Study P04272)	Completed	Integrated Therapeutics Group	Phase 4	2005-09-01	This study is being conducted to determine if the co-administration of formoterol fumarate and tiotropium bromide is more effective than the use of tiotropium bromide alone in patients with COPD.
NCT00139932	Tiotropium Bromide Alone vs Tiotropium Bromide and Formoterol Fumarate in Subjects With COPD (Study P04272)	Completed	Novartis	Phase 4	2005-09-01	This study is being conducted to determine if the co-administration of formoterol fumarate and tiotropium bromide is more effective than the use of tiotropium bromide alone in patients with COPD.
NCT00139932	Tiotropium Bromide Alone vs Tiotropium Bromide and Formoterol Fumarate in Subjects With COPD (Study P04272)	Completed	Merck Sharp & Dohme Corp.	Phase 4	2005-09-01	This study is being conducted to determine if the co-administration of formoterol fumarate and tiotropium bromide is more effective than the use of tiotropium bromide alone in patients with COPD.
NCT00144326	A Randomised, Double-blind, Placebo-controlled, 12 Week Trial to Evaluate the Effect of Tiotropium Inhalation Capsules (Spiriva) on the Magnitude of Exercise, Measured Using an Accelerometer, in Patients With Chronic Obstructive Pulmonary Disease (CO	Completed	Boehringer Ingelheim	Phase 3	2003-07-01	The objective of this study is to determine if tiotropium (Spiriva, Bromuro de Tiotropio) 18 mcg once daily by oral inhalation compared to placebo increases the magnitude of daily physical activity observed in COPD patients, measured using an accelerometer.

Clinical Trial Conditions for Tiotropium Bromide

Condition Name

Condition Name for Tiotropium Bromide
Intervention	Trials
Pulmonary Disease, Chronic Obstructive	49
Chronic Obstructive Pulmonary Disease	20
COPD	11
Asthma	9

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Tiotropium Bromide
Intervention	Trials
Pulmonary Disease, Chronic Obstructive	79
Lung Diseases	75
Chronic Disease	49
Lung Diseases, Obstructive	43

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Tiotropium Bromide

Trials by Country

Trials by Country for Tiotropium Bromide
Location	Trials
United States	437
Germany	64
Canada	63
Italy	35
Japan	31

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Tiotropium Bromide
Location	Trials
California	25
South Carolina	24
Texas	23
Florida	23
North Carolina	18

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Tiotropium Bromide

Clinical Trial Phase

Clinical Trial Phase for Tiotropium Bromide
Clinical Trial Phase	Trials
Phase 4	32
Phase 3	32
Phase 2	21

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Tiotropium Bromide
Clinical Trial Phase	Trials
Completed	88
Recruiting	9
Terminated	3

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Tiotropium Bromide

Sponsor Name

Sponsor Name for Tiotropium Bromide
Sponsor	Trials
Boehringer Ingelheim	47
GlaxoSmithKline	15
Novartis	6

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Tiotropium Bromide
Sponsor	Trials
Industry	97
Other	42
NIH	2

Export unavailable in trial.
Subscribe for complete access.